Diversity of enrollment in prostate cancer clinical trials: Current status and future directions

被引：0

作者：

Rencsok, Emily ^{[1
]}

Bazzi, Latifa ^{[2
]}

McKay, Rana ^{[3
]}

Huang, Franklin ^{[4
]}

Friedant, Adam ^{[5
]}

Vinson, Jake ^{[5
]}

Zarif, Jelani ^{[6
]}

Simmons, Stacey ^{[7
]}

Villanti, Paul ^{[8
]}

Kantoff, Philip ^{[9
]}

Heath, Elisabeth ^{[10
]}

George, Daniel ^{[11
]}

Mucci, Lorelei ^{[12
]}

机构：

[1] Harvard Med Sch, Boston, MA 02115 USA

[2] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA

[3] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Prostate Canc Clin Trials Consortium, New York, NY USA

[6] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[7] Bayer Oncol, Whippany, NJ USA

[8] Movember Fdn, East Melbourne, Vic, Australia

[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[10] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[11] Duke Canc Inst, Durham, NC USA

[12] Harvard TH Chan Sch Publ Hlth, Boston, MA USA

来源：

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2020年 / 29卷 / 06期

关键词：

D O I：

10.1158/1538-7755.DISP18-B022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B022

引用

页数：2

共 50 条

[1] Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions
Rencsok, Emily M.
Bazzi, Latifa A.
McKay, Rana R.
Huang, Franklin W.
Friedant, Adam
Vinson, Jake
Peisch, Samuel
Zarif, Jelani C.
Simmons, Stacey
Hawthorne, Kelly
Villanti, Paul
Kantoff, Philip W.
Heath, Elisabeth
George, Daniel J.
Mucci, Lorelei A.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (07) : 1374 - 1380
[2] Current Status and Future Directions for Clinical Trials Pharmacy
La, Hyen-Oh
Choi, Sun
Lee, Soo-Kyung
Ryu, Byeung-Eun
Han, Ok-Yeon
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (06): : 969 - 975
[3] Screening for Prostate Cancer: Current Status and Future Directions
Gershman, Boris
Karnes, R. Jeffrey
EUROPEAN UROLOGY FOCUS, 2015, 1 (02): : 147 - 148
[4] Prostate Cancer Registries: Current Status and Future Directions
Gandaglia, Giorgio
Bray, Freddie
Cooperberg, Matthew R.
Karnes, R. Jeffrey
Leveridge, Michael J.
Moretti, Kim
Murphy, Declan G.
Penson, David F.
Miller, David C.
EUROPEAN UROLOGY, 2016, 69 (06) : 998 - 1012
[5] Chemoprevention of prostate cancer: Current status and future directions
Lieberman, R
CANCER AND METASTASIS REVIEWS, 2002, 21 (3-4) : 297 - 309
[6] Chemoprevention of Prostate Cancer: Current Status and Future Directions
Ronald Lieberman
Cancer and Metastasis Reviews, 2002, 21 : 297 - 309
[7] Current and Future Directions of Clinical Trials for Ovarian Cancer
Gardner, Ginger J.
Jewell, Elizabeth L.
CANCER CONTROL, 2011, 18 (01) : 44 - 51
[8] Randomized phase II designs in cancer clinical trials: Current status and future directions
Lee, JJ
Feng, L
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) : 4450 - 4457
[9] RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
Barata, Pedro
Sood, Anil K.
Hong, David S.
CANCER TREATMENT REVIEWS, 2016, 50 : 35 - 47
[10] The treatment of neuroendocrine prostate cancer; current status and future directions
Rescigno, Pasquale
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2019, 6 (03)

← 1 2 3 4 5 →